iDEL Therapeutics
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $10M
Investors
- 4
About iDEL Therapeutics
iDEL Therapeutics GmbH is focused on creating advanced synthetic shuttle technologies for cancer therapy. Founded in 2025 in Dortmund, Germany, the company has executed one deal as of March 2026.Venture, Grunderfonds Ruhr, and Khanu Management.iDEL Therapeutics specializes in developing a novel synthetic shuttle platform for the direct delivery of therapeutic payloads into tumor cell cytosol. This technology targets previously inaccessible cancer drivers, enhancing the efficacy of treatments for various cancer indications. Their lead candidates focus on intracellular oncogene targeting and multicancer drug conjugates, currently in preclinical evaluation. Their business model relies on strategic alliances to develop and commercialize therapeutic products, facilitating shared investment in research and clinical trials. The company plans to expand its market presence in North America and Europe, targeting the high prevalence of cancer in these regions.
Who invested in iDEL Therapeutics
4 investors across 1 round
See all investors in iDEL Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 14, 2025
Amount
$10M
Investors
Questions about iDEL Therapeutics
Who invested in iDEL Therapeutics?
iDEL Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iDEL Therapeutics raised?
iDEL Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iDEL Therapeutics last raise money?
iDEL Therapeutics's most recent round on record is a Seed, in Oct 2025.
What does iDEL Therapeutics do?
iDEL Therapeutics GmbH is focused on creating advanced synthetic shuttle technologies for cancer therapy.
Where is iDEL Therapeutics headquartered?
iDEL Therapeutics is headquartered in Dortmund, Germany.
Which VCs invest in companies like iDEL Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at iDEL Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like iDEL Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.